115 Followers on Owler
Amicus is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
Amicus is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
Amicus Therapeutics President & CEO: Bradley L Campbell

President & CEO

Bradley L Campbell

CEO Approval Rating

82/100

2002

PublicAcquired by BioMarin Pharmaceutical Inc.NASDAQFOLD

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
$634.2M
Employees
480
Funding
$1.3B
Acquisitions
3

News

Acquisition
Dec 19, 2025
The Wall Street Journal
Amicus Was acquired by BioMarin Pharmaceutical Inc. for $4.8B

Amicus Therapeutics Competitors

1Sanofi
2Takeda Pharmaceutical
3Idorsia
4Protalix
5Freeline
6Sangamo
74DMT
8Bayer
9Astellas
10Roche
Unlock 22 + competitors

Trending Companies